Skip to main
WAT

Waters (WAT) Stock Forecast & Price Target

Waters (WAT) Analyst Ratings

Based on 17 analyst ratings
Buy
Strong Buy 29%
Buy 29%
Hold 41%
Sell 0%
Strong Sell 0%

Bulls say

Waters is a company with strong potential for growth, especially in the diagnostics and biosciences sectors, following its merger with Becton Dickinson in early 2026. The company also has a strong management team and a solid reputation in the pharmaceutical market. However, the high levels of debt and limited data on pricing for global shipping present potential risks for the company's financials and the broader Medical and Life Science Tools sector. Investors should monitor the company's capital allocation strategies and closely follow any price increases for their products.

Bears say

Waters is a company that has expanded its market through a recent merger with Becton Dickinson's life science and diagnostics business, but with its increased concentration in diagnostics and discovery-related life science tools, the negative outlook is justified. The integration of BD assets adds operational complexity at a potential industry inflection point, and the risk of integration hiccups and growth disappointment could compress the company's valuation. Additionally, concerns over its sustainability efforts and potential pricing pressure due to increased scrutiny and regulatory expectations could further impact the company's future growth potential.

Waters (WAT) has been analyzed by 17 analysts, with a consensus rating of Buy. 29% of analysts recommend a Strong Buy, 29% recommend Buy, 41% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Waters and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Waters (WAT) Forecast

Analysts have given Waters (WAT) a Buy based on their latest research and market trends.

According to 17 analysts, Waters (WAT) has a Buy consensus rating as of Aug 9, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $412.94, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $412.94, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Waters (WAT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.